Altfest L J & CO Inc Vertex Pharmaceuticals Inc Transaction History

Altfest L J & CO Inc

$706 Million
Q1 2024

A detailed history of Altfest L J & CO Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Altfest L J & CO Inc holds 1,437 shares of VRTX stock, worth $706,457. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,437

Previous 1,432 0.35%

Holding current value

$706,457

Previous $583,000 3.09%

% of portfolio

0.09%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$407.69 - $446.08 $2,038 - $2,230	5 Added 0.35%	1,437 $601,000
Q4 2023 Jan 18, 2024	SELL	$343.0 - $410.68 $6,174 - $7,392	-18 Reduced 1.24%	1,432 $583,000
Q3 2023 Oct 26, 2023	SELL	$338.18 - $362.46 $27,730 - $29,721	-82 Reduced 5.35%	1,450 $504,000
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $23,895 - $26,745	76 Added 5.22%	1,532 $539,000
Q1 2023 Apr 20, 2023	BUY	$283.23 - $323.1 $49,848 - $56,865	176 Added 13.75%	1,456 $459,000

Q4 2022 Feb 02, 2023	SELL	$285.76 - $321.48 $335,768 - $377,739	-1,175 Reduced 47.86%	1,280 $370,000
Q3 2022 Nov 15, 2022	SELL	$273.83 - $305.53 $821 - $916	-3 Reduced 0.12%	2,455 $711,000
Q2 2022 Aug 04, 2022	SELL	$234.96 - $292.55 $133,692 - $166,460	-569 Reduced 18.8%	2,458 $693,000
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $17,935 - $21,138	81 Added 2.75%	3,027 $790,000
Q4 2021 Jan 24, 2022	SELL	$177.01 - $223.45 $2,655 - $3,351	-15 Reduced 0.51%	2,946 $647,000
Q3 2021 Oct 12, 2021	BUY	$181.39 - $202.99 $212,226 - $237,498	1,170 Added 65.33%	2,961 $537,000
Q2 2021 Jul 28, 2021	BUY	$187.49 - $221.1 $40,497 - $47,757	216 Added 13.71%	1,791 $361,000
Q1 2021 May 07, 2021	BUY	$207.02 - $241.31 $4,554 - $5,308	22 Added 1.42%	1,575 $338,000
Q4 2020 Jan 21, 2021	BUY	$207.01 - $276.09 $321,486 - $428,767	1,553 New	1,553 $367,000

Others Institutions Holding VRTX

# of Institutions

1,626

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $126B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account